Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study
Medical Mycology · 2024
DOI: 10.1093/mmy/myae064 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Mycology, 2024. Verfasst von Meyha Sahin und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Mucormycosis, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
The emergence of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), triggered a global pandemic. Concurrently, reports of mucormycosis cases surged, particularly during the second wave in India. This study aims to investigate mortality factors in COVID-19-associated mucormycosis (CAM) cases, exploring clinical, demographic, and therapeutic variables across mostly Asian and partly African countries. A retrospective, cross-sectional analysis of CAM patients from 22 medical centers across eight countries was conducted, focusing on the first 3 months post-COVID-19 diagnosis. Data collected through the ID-IRI included demographics, comorbidities, treatments, and outcomes. A total of 162 CAM patients were included. The mean age was 54.29 ± 13.04 years, with 54% male. Diabetes mellitus (85%) was prevalent, and 91% had rhino-orbital-cerebral mucormycosis. Surgical debridement was performed in 84% of the cases. Mortality was 39%, with advanced age (hazard ratio [HR] = 1.06, [P < .001]), rituximab use (HR = 21.2, P = .05), and diabetic ketoacidosis (HR = 3.58, P = .009) identified as risk factors. The mortality risk increases by approximately 5.6% for each additional year of age. Surgical debridement based on organ involvement correlated with higher survival (HR = 8.81, P < .001). The utilization of rituximab and diabetic ketoacidosis, along with advancing age, has been associated with an increased risk of mortality in CAM patients. A combination of antifungal treatment and surgical intervention has demonstrated a substantial improvement in survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, Istanbul, Turkey.
- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Infectious Diseases and Tropical Medicine, Shahid Beheshti University of Medical Sciences, Loghman Hakim Hospital, Tehran, Iran.
- Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Hematology-Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Medicine, Gajju Khan Medical College, Swabi, Pakistan.
ORCID-Profile: Meyha Sahin, Abdolreza Babamahmoodi
Zitieren
APA
Sahin, M., Yilmaz, M., Mert, A., Naghili, B., Ravanbakhsh, F., Varshochi, M., Darazam, I. A., Ebrahimi, M. J., Moafi, M., Tehrani, H. A., Mahboob, A., Rashid, N., Khan, E. A., Hakamifard, A., Eser-Karlidag, G., Babamahmoodi, A., El-Kholy, A., Mosawi, S. H., Albayrak, A., …, & Erdem, H. (2024). Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study. Medical Mycology. https://doi.org/10.1093/mmy/myae064
Vancouver
Sahin M, Yilmaz M, Mert A, Naghili B, Ravanbakhsh F, Varshochi M, et al. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study. Medical Mycology. 2024. doi:10.1093/mmy/myae064
BibTeX
@article{Sahin2024,
author = {Sahin, Meyha and Yilmaz, Mesut and Mert, Ali and Naghili, Behrouz and Ravanbakhsh, Fatemeh and Varshochi, Mojtaba and Darazam, Ilad Alavi and Ebrahimi, Mohammad Javad and Moafi, Maral and Tehrani, Hamed Azhdari and Mahboob, Amjad and Rashid, Naveed and Khan, Ejaz Ahmed and Hakamifard, Atousa and Eser-Karlidag, Gülden and Babamahmoodi, Abdolreza and El-Kholy, Amani and Mosawi, Sayed Hussain and Albayrak, Ayşe and Al Ramahi, Jamal Wadi and Addepalli, Syam Kumar and Özer Balin, Şafak and Khan, Asfandiyar and Pandya, Nirav and Gurbuz, Esra and Sincan, Gülden and Azami, Hadia and Dumlu, Rıdvan and Khedr, Reham and Ripon, Rezaul Karim and Alkan, Sevil and Kose, Şükran and Ceylan, Bahadır and Erdem, Hakan},
title = {Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study},
journal = {Medical Mycology},
year = {2024},
doi = {10.1093/mmy/myae064}
}
EUVIMED